Health & BiotechnologyEconomy
China's Biotech Surge at ASCO 2026 Challenges US Dominance
Chinese biotech firms set records at ASCO 2026 with 95 abstracts and a $10.5B Pfizer-Innovent deal, fueling concerns over US drug dominance.
—5 min read
Tag
#Us China Competition
2 articles
TechnologyPolitics
Trump Halts AI Executive Order Over Competitiveness Concerns
President Trump canceled the signing of an AI executive order hours before the ceremony, worrying it could weaken America's technological edge over China.
—5 min read